This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Operator
Conference Operator
Good morning and welcome to the CBOE Global Markets first quarter 2023 earnings conference call. All participants will be in the listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Ken Hill, Vice President of Investor Relations at SIBO Global Markets. Please go ahead.
Ken Hill
Vice President of Investor Relations
Good morning. Thank you for joining us for our first quarter earnings conference call. On the call today, Ed Tilley, our Chairman and CEO, will discuss our performance for the quarter and provide an update on our strategic initiatives. Then, Brian Schell, our Executive Vice President, CFO and Treasurer, results for the quarter, as well as discuss our 2023 financial outlook. Following their comments, we will open the call to Q&A. Also joining us for Q&A will be Chris Isaacson, our Chief Operating Officer, Dave Howson, our President, and our Chief Strategy Officer, John Dieters. I'd like to point out that this presentation will include the use of slides. We will be showing the slides and providing commentary on each. A downloadable copy of the slide presentation is available on the Investor Relations portion of our website. During our remarks, we'll make some forward-looking statements, which represent our current judgment on what the future may hold. And while we believe these judgments are reasonable, these forward-looking statements are not guarantees of future performance and involve certain assumptions, risks, and uncertainties. Actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. Please refer to our filings with the SEC for a full discussion of the factors that may affect any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise after this conference call. During the call this morning, we'll be referring to non-GAAP measures as defined and outlined in the earnings materials. Now I'd like to turn the call over to Ed.
Ed Tilley
Chairman and CEO
Thank you, Ken. Good morning, and thanks for joining us today. to continually innovate to meet the evolving needs of the global financial industry. From pioneering options and volatility trading to introducing new technologies and market models, SIBO has transformed the way market participants transfer risk and build capital. Our series of strategic acquisitions in recent years have greatly expanded the breadth and depth of the SIBO network, making us the dynamic company that we are today. Each and every quarter we have built upon our strong foundation, and this quarter is no different. I'm pleased to report on record first quarter earnings for CBOE, reflecting the continued endurance of our business. During the quarter, we grew net revenue by 13% year over year to a record $471 million and adjusted EPS by 10% to a record $1.90. These record-breaking first quarter results We're driven by strong volumes across our derivatives franchise, specifically our proprietary index option products and the continued global expansion of our data and access solutions business. Our derivatives business delivered another outstanding quarter as total net revenue increased 29% driven by the strength of our index options and volatility products and solid volumes in multi-list options trading. During the quarter, Total net revenue in our data and access solutions business increased 9%, while total net revenue in our cash and spot markets business decreased 12%. We continue to make progress, delivering on our top strategic growth priorities, derivatives, data and access solutions, and SIBO Digital. I'll touch on derivatives and data and access solutions in a moment, but first I want to provide an update on SIBO Digital. During the quarter, SIBO Digital continued to onboard new participants as liquidity deepened and our spreads compressed to competitive levels compared to other U.S.-based platforms. February represented our best month to date, with ADV of more than $100 million. We had a record first quarter with $7.4 billion traded. 2023 is not only an anniversary year for SIBO, but it also marks the 40th anniversary of SBX Options and the 30th anniversary of the VIX Index. The success of both our VIX franchise and suite of S&P 500 index option products is a result of years of innovation and perseverance, driven by our unwavering belief in the potential from the beginning. Trading these products was robust during the quarter. The recent enhancements implemented to expand access to SPX and XSP, including expanded trading hours and new expirations, have created new opportunities for customers. During the first quarter, SBX Options ADV increased 59% to a record 2.8 million contracts, including a single-day record of 4.2 million contracts traded on March 10. Building on the strong momentum we saw last quarter, our mini-SBX Options contract, known by the ticker XSP, increased 195% year-over-year. Additionally, ADV for PICS Options increased 18% year-over-year in the first quarter, as they engaged in tactical trading strategies around market events. ADP for SPX options opened on the same day of expiration, otherwise called zero DTE, comprised nearly 43% of overall SPX volumes in the first quarter and nearly 45% of SPX volume in April. We believe there has been a fundamental evolution in how customers are trading their to see increased demand from our non-U.S. customers and liquidity providers for the ability to trade SPX and VIX products across all time zones day and night. As a result, we have seen sizable increase in volume during our global trading hour session with ADV for SPX and VIX options increasing 121% and 118% respectively year over year. Turning to our VIX products, ADV for VIX options increased 18% year over year to over 718,000 contracts traded in the first quarter, while VIX Futures' ADV remained steady at 223,000 contracts. First quarter volume in multi-listed options increased 1% to an ADV of 11 million contracts. In March, SIBO reached a record 337 million total contracts traded across its four options exchanges. Fifty years ago, we founded the listed options industry, and despite its immense growth, We believe that we are still in the early stages of the evolution of this market. We continue to lead the industry forward through continued enhancements to our ecosystem of products to suit the needs of various customers. Most recently, we announced the launch of the Zeebo One Day Volatility Index. The market seeks to measure the expected volatility of the S&P 500 index over the current trading day. Just as the VIX index has grown to become one of the most recognized tools in the marketplace, We believe the one-day VIX index will be a complementary addition for market participants seeking to better understand current equity market volatility. During the quarter, we were also excited to announce our plans to expand the product suite of SIBO Europe derivatives to include single-stock options on leading European companies. These products are expected to be available for trading in November of 2023 and cleared by SIBO Clear Europe, subject to necessary regulatory approvals. With the utility and flexibility that options provide in any market environment, as well as the varied trading strategies utilized by a diverse customer base, we believe we will continue to see demand from new and existing customers as they discover the benefits options can provide to their portfolios. We are pleased with the continued solid growth of our data and access solutions business, which posted another strong quarter, with total net revenue increasing 9%. We continue to enhance our bundled data offerings and cloud strategy, packaging high-quality data from across our markets and delivering it to customers globally in a consistent and cost-effective manner, extending the reach of our content and the opportunity for this business. During the quarter, we were excited to launch the SIBO One Options Feed, a product designed for the retail options trading community. This high-quality data feed provides retail investors with cost-effective, real-time data. SIBO knows it is imperative to help equip the burgeoning retail community with the information they may need to invest responsibly. SIBO's enduring success over the past half century is reflected in the unrivaled position that we hold today across our global derivatives and securities ecosystem. I've covered our derivatives business and will now touch on highlights from our cash and spot market. notional value traded of $45 billion. In Europe, the SIBO Europe equities business increased first quarter market share three percentage points year over year to 24.9%. Additionally, SIBO Bids Europe had another strong quarter with 36.3% market share, extending its run as the largest European block trading venue to 12 consecutive months. SIBO cleared market share to 34.1% in the first quarter, In Japan, we saw our equities market share grow to 4.8% during the first quarter, up from 3.8% a year ago. We also remain on track for the SIBO Japan technology migration, an expected launch of SIBO Bids Japan in the fourth quarter of this year, subject to regulatory approval, further extending our reach of the bids network into another key global equity market. In summary, SIBO delivered an outstanding first quarter to start the year. continuing the momentum of our record 2022. While we have a long-term view of our business, we are committed to investing in the near term to lay a solid foundation for future sustainable growth. With this perspective, we are confident we can build on our success and continue to deliver value to our customers and shareholders for the next 50 years. With that, I'll turn it over to Brian.
Brian Schell
Executive Vice President, CFO and Treasurer
Thank you, Ed. As Ed highlighted, SIBO posted another record quarter since growth of our derivatives franchise, as well as a steady contribution from our data and access solutions business. OneQ was not only a period of robust financial performance, but it also marked a period of meaningful advancement for many of our strategic initiatives. We believe that striking the right balance between monetizing today's opportunities and investing in the future of our company is crucial for the long-term growth of CBO. I want to quickly touch on some of the high-level takeaways from the first quarter. Our first quarter net revenue increase of 13% set another quarterly record at $471 million, led by the strength in our derivatives markets category and the solid results from our data and access solutions business. Specifically, derivatives markets produced 29% year-over-year organic net revenue growth in the first quarter as the market continued to find increasing utility in our index options complex with the rise of zero DTE trading and global trading hours. Data and access solutions net revenues increased 9%, up 6% on an organic basis during the quarter. We are pleased with the overall performance of the category and even more excited by the numerous catalysts we expect to accelerate growth over the course of this year. Cash-to-spot markets net revenues decreased 12% during the quarter or 13% on an organic basis as we face difficult industry volume comparisons versus the first quarter of 2022. and a three percentage point impact from a stronger dollar. Adjusted operating expenses increased 28% to $186 million. An adjusted EBITDA of $310 million also notched a quarterly high of 10% from the first quarter of 22. Turn to the key drivers by segment. Our press release and the appendix of our slide deck include information detailing the key metrics. For each of our business segments, I'll just provide a summary thought. The performance of our options segment was again very strong, delivering the highest growth of any segment for the quarter with net revenue increasing 28%. Results were driven by robust volumes in our index business and strong revenue per contract or RPC given the favorable mixed shift trends. Total options ADV was up 9% as our higher priced index options ADV increased 49% over 1Q22 levels. RPC moved 27% higher. given a continued positive contribution of index options and a stronger mix of higher-priced SPX options in our index business. And market data and access capacity fees were up 8% and 9%, respectively, as compared to 1Q22. One additional item worth calling out for this segment in the first quarter was the 51% year-over-year increase in options royalty fees, somewhat higher than previous quarterly growth rates. Roughly 75% of the increase was related to higher volumes in our SPX and VIX options. The remaining 25% of the increase was related to the last scheduled reset in royalty fees with S&P, which took effect at the beginning of the first quarter. This last scheduled adjustment to contract rates is part of our current agreement with S&P that runs through 2032-33, making the first quarter a good run rate ratio of royalty fees to proprietary volume moving forward. North American equities net revenue was flat on a year-over-year basis. Results benefited from NEO, which was acquired in June of 22, contributing $5.6 million in net revenue during the quarter. Net transaction fees were flat given softer industry volumes and market share in our U.S. businesses. And while our U.S. on-exchange market share has trended lower on an absolute basis, our share has remained relatively constant when adjusting for the increase in off-exchange market volume activity seen during 1Q. The industry volume and market share headwinds were offset by the positive contribution a 14% year-over-year decline in net revenue. However, adjusting for a $3.5 million FX impact given the stronger dollar during the quarter, net revenue fell by a more modest 8% on a constant currency basis, impacted by softer volumes in Europe. The lower activity levels were partially offset by a 3.1 percentage point increase in market share on a year-over-year basis, making SIBO Europe the largest stock exchange in Europe again. And SIBO Clear Yelp also grew market share during the quarter from 32% to 34%. First quarter net revenue was flattened in the futures segment as a 4% decline in net transaction fees was offset by an increase in access and capacity fees. Lower volumes were the primary driver of the decline in net transaction fees, falling 9% during the quarter. Non-transaction revenues continued to perform well with access and capacity fees up 18% and market data flattened. to the first quarter of last year. And finally, net revenue in the FX segment was up 8% compared to last year, building on the very strong momentum we saw from the FX segment during 22. Net transaction fee revenue was up 8% as average daily notional value increased by 7%, and market share hit another record at 19% for the quarter. Turning now to CBOE's data and access solutions business, net revenues We're up a solid 9% in the first quarter, up 6.2% on an organic basis. Net revenue growth continued to be driven by additional subscriptions and units, accounting for 70% of access fee and market data growth in the first quarter. While our 6.2% organic net revenue growth rate for the quarter finished slightly below the low end of our 7% to 10% full-year guidance range, we feel confident in our ability to accelerate trends Specifically, with the recent launch of SIBO 1 options, we expect to see an uptake of clients for all of our SIBO 1 data feeds in the second half of 2023, adding incremental revenue for the DNA business. In Australia, we finished our successful technology migration and launched our bids offering in the region at the end of the first quarter. Following the migration, we expect to see increased demand for SIBO data in Australia, consistent with what we have seen following past technology migrations around the globe. Added to that positive momentum is the enhanced distribution that SIBO Global Cloud now provides, offering incremental sales potential for our suite of data products. We also anticipate solid trends from SIBO Global entities with good momentum around index licensing. We are experiencing new global customer wins in risk and market analytics and see opportunities coming online in distribution. From a timing perspective, we anticipate most of this second half of 23, landing us in our 7% to 10% organic net revenue growth guidance range for the full year and putting us in line with our medium-term expectations outlined at our November 2021 investor day. Turning to expenses, total adjusted operating expenses were approximately $186 million for the quarter, up 28% compared to last year. Excluding the impact of acquisitions owned less than a year, adjusted operating $28 million for the quarter, largely reflecting higher headcount as compared to the first quarter of last year, as well as some inflationary comp adjustments and higher professional fees and outside services as compared to 1Q22. Moving to our expense guidance, we are reaffirming our full year 23 expense guidance range of $769 to $779 million. This compares to our 2022 expense base of $652 million. three basic components of the year-over-year increase are outlined on slide 17 of our earnings presentation, expenses from 2022 acquisitions, growth investments, and core expense growth. At a high level, while the aggregate expense range remains unchanged, we expect a $3 million reduction in expenses from 2022 acquisitions to be entirely offset by higher anticipated consolidated audit trail, or CAD, that we have limited control over. Looking at the details of our three expense categories, we anticipate the 2022 acquisitions of NEO and ARISX will add approximately $33 to $35 million in incremental expenses in 23. We are again calling out growth-generating investments given the numerous attractive opportunities we see today. These are investments we are making today to help drive incremental revenue to our bottom line in future years. Specifically, we are investing in global listings, DNA expansion, a more aggressive marketing campaign, and targeted product and services R&D efforts across our ecosystem. In 2023, we continue to expect growth investments to be in the range of $28 to $30 million. The last component and the largest portion of the year-over-year increase remains our core expense growth, totaling approximately $56 to $62 million. Our new range is $3 million higher than last quarter remains unchanged. We will continue to exhibit operational efficiency while investing where we see opportunities over time. We believe the investments we are making today position SIBO well to generate attractive returns in the years ahead. Now turning to a summary of full year guidance on the next slide, we are reaffirming the 23 guidance we introduced last quarter. In addition to the previously noted DNA organic net revenue growth rate of 7% to 10% range, and we are reaffirming our organic total net revenue growth range of 7% to 9% for 23. This remains above our medium-term guidance of 5% to 7% introduced at our investor day a year and a half ago. A function of our confidence in the durable growth of our business and the progress we are seeing behind the investments we have made to increase the access and distribution of our products and markets globally. Last quarter, we introduced guidance calling for minority investments benefiting our other income line. In one Q, we recognize a $14 million gain on the company's investment in Seven Ridge Fund, which owns Trading Technologies, and are reaffirming our full-year expectation of a $27 to $33 million benefit. We look for the impact of minority investments to become a regular and recurring contributor to company earnings and are providing our best estimate of the benefit we anticipate in 2023. We are also reaffirming our full-year guidance on depreciation and amortization of $48 to $52 million and expect the effective tax rate on adjusted earnings under the current tax laws to come in at 28.5 to 30.5% in 2023. Outside of our annual guidance, that interest expense for the first quarter of In the first quarter, we returned a total of $123 million to shareholders in the form of a $0.50 per share quarterly dividend and $70 million in the form of share repurchases. Overall, we remain well positioned to invest in the business, support our dividend, and opportunistically repurchase shares when we believe our stock price does not adequately reflect the underlying fundamentals of our business as we did in the first quarter. We have $148 million in remaining capacity on our share repurchase authorization as of April 30, 2023. Our leverage ratio for the quarter remained at 1.5 times in line with fourth quarter levels. We remained comfortable with our debt profile, having locked in low, medium, to longer-term fixed rates, averaging below 3% on over 80% of our total debt. In summary, the first quarter of 2023 was an excellent start to the year. behind the numerous growth initiatives we have, generating durable returns for shareholders in many quarters and years to come. Now, I'd like to turn it back over to Ed for some closing comments before we open it up to Q&A. Thanks, Brian.
Ed Tilley
Chairman and CEO
In closing, I want to thank our valued customers who engage with us every day, providing liquidity to our markets, utilizing our products and services, and supporting our vision. They are valued partners that have been critical to our success over the last 50 years. I'm extremely proud of our people, past and present, who have helped build an incredible company and continue to chart the future success for SIBO. Our 50-year legacy is built on trust, relentless innovation, and a drive to disrupt the status quo, powered by the exceptional strength of our people. Together, we have created an exchange like no other, the exchange for the world stage.
Ken Hill
Vice President of Investor Relations
At this point, we'd be happy to take questions. We ask that you please limit your questions to one per person to allow time to get to everyone. Feel free to get back in the queue, and if time permits, we'll take a second question.
Operator
Conference Operator
We will now begin the question and answer session. To ask a question, you may press star then 1 on your telephone keypad. If you're using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed, and you would like to withdraw your question, please press star then two. Again, please limit yourself to one question and feel free to rejoin the queue. At this time, we will pause momentarily to assemble our roster. The first question comes from Rich Rapetto with Piper Sandler. Please go ahead.
Rich Rapetto
Analyst at Piper Sandler
Good morning, Ed. Good morning. Good morning. And I agree, you guys continue to rewrite how people look at risk management. And, you know, the zero DTE stuff has been the most resilient asset class, you know, since the spike in volume and volatility in March even. So I guess my question relates to the new thing, the things that you can do to continue that on. You know, can you talk about maybe how the one-day VIX, one-day BAL, index could impact trading and this XXP contract? And then is there any possibility you see other exchanges with proprietary products increasing pricing? Any possibility of leveraging pricing on these products?
Ed Tilley
Chairman and CEO
Really good. Let's take a half a step back and deal with the VIX one day first, and then we'll go over to Dave on product benchmark VIX, the 30-day implied number. We use real prices, remember, Rich, of the S&P 500 to calculate that non-tradable benchmark. And that was really put out to the marketplace as information. We believe that the more information and transparency that we have into the markets, the better informed customers, traders will be. So it's that line of development that we follow with the You point out the explosive growth of zeros that started about a year ago, which we say close to half of the SPX volume in one- and two-day expiry. The 30-day VIX number was not capturing the implied volatility in one and two days. And so we wanted to put a benchmark out there that informed the market on what short-term implied volatility looked like, a better picture. So think of it this way. If you look at the Chicago 10-day forecast, May 16th, for example, I'd say 70 and sunny. And that's really interesting until you go outside and it's 40 and raining. Is the 10-day wrong? Absolutely not. We're just not capturing. We're looking through today's thunderstorm and looking out 10 days. We wanted to capture today's forecast, and that is what the implied volatility measure in one day, and that is to inform investors on a better look at short-term uncertainty. Now, expansion and pricing and growth. Let me turn it over to Dave, and we'll give you a little bit more color on the zeros.
Dave Howson
President and Chief Strategy Officer
Thanks, Ed, and thanks, Rich, for pointing out the sustained and consistent volumes there in the zero days to expiration. As we look at the SBX family, we do really see it as a family of products. And you mentioned the XSP product, the one-tenth size contract of the SBX. What we see, you can see in the figures there, some good growth of the XSP contract itself as customers also begin to find utility in the small products. And what we find is through the education of end users and customers, they're coming to the complex and growing. We hear from our customers that new account openings meaningfully increased in Q1 with those customers trading the SPX and the XSP family. And indeed, we see graduations from XSP user to SPX, as well as people finding also utility in the XSP contract itself. You talked about pricing there as well, Rich. And when we look across, actually, our business in general, our priority is expanding access and distribution, getting that incremental user in the products or viewing our data. So at this point in time, we don't see a particular need for us to increase our pricing across the product landscape at this point. Really, it's about further adoption. And when we look at the trends, it looks very positive.
Rich Rapetto
Analyst at Piper Sandler
Got it. Thank you, and thanks for the weather analogy. That helps.
Ed Tilley
Chairman and CEO
Thanks a lot, Rich. Thanks.
Operator
Conference Operator
The next question comes from Michael Sipris with Morgan Stanley. Please go ahead.
Michael Sipris
Analyst at Morgan Stanley
Great. Thank you. Good morning. Maybe just continuing with the last thread around continuing to drive further adoption, just on the XPX product, maybe you could talk about the institutional usage of the zero DTEs. Where does that stand today? What are some of the steps that you guys can take to increase usage by institutions for zero DTEs, and what are some of the most compelling use cases that you're seeing there, and how that may differ from other customer sets that are using the zero DTEs? Thank you.
Ed Tilley
Chairman and CEO
Yeah, I think what we really try to point to and distinguish what's been written, and we've been very consistent saying that the first adoption, the first users, as I say, almost a year ago, were coming from retail platforms primarily. That does not mean that this was a retail play. So we think institutional, more professional customers coming off that IV platform and think or swim. Those were the ones that we have been pointing out over time as the early adopters. Now we see a more broad use. We see higher-touch desks engaging. Look, we're informed by our customers. We are in the business of listening. And, you know, we listened to Thomas Petipi, who gave color from the IB platform and said the adoption is just beginning in some of the categories and the users. more and more adoption. And as for the use case, it really is to capture the news of the day. This really allows investors to pinpoint the uncertainty in the daily news cycle to trade around that news without buying weeks or months of premium to hedge against or take a position in short-term moves. Great example, two days ago. I don't want Friday exposure. I want to know and hedge around what the Fed is going to say, you know, 1.30 central time, and that's the risk I'm trying to isolate. One day is a perfect example on how to capture that move without having to buy premium that lasts days and weeks and months into the future. So we are measuring the potential in the amount of imbalance that we have for data around and modeling short-term exposure and the data around what is trading, open interest, strike, the dispersion around various strikes in one day. So we know that there's a great amount of study and backtesting going on with the use case, and we're encouraged by the commentary and the feedback that we're getting from our user groups more broadly, not just in the first movers.
Operator
Conference Operator
Great. Thank you. The next question comes from Daniel Fannin with Jefferies. Please go ahead.
Daniel Fannin
Analyst at Jefferies
Thanks. Good morning. I wanted to follow up on data and access solutions. The 6% growth, and then you have your medium-term target of 7 to 10, and Brian, you walked through, I think, several upcoming rollouts in the back half of the year that should accelerate growth. I was hoping you could maybe contextualize or put some numbers around some of those initiatives. You talked about bids as an example where you've rolled it out before. Maybe help us think about what that's been in terms of incremental contribution. And it seems like that could, all those initiatives could make maybe next year's numbers look like some, you know, even higher than some of the metrics we've seen here recently. So I wanted to get a little bit further into what you talked about.
Brian Schell
Executive Vice President, CFO and Treasurer
Yeah, well, I think I'll tag team this with Dave as we kind of as we Excuse me, roll this out. So I think I'm going to stop short of giving you kind of specific numbers for each of those three categories. I think what we were trying to paint the picture is there's a pretty strong pipeline within each of those categories that, you know, based on client feedback of, you know, near signing, signing hasn't started to kick in. So each of those items, right? So as we kind of break respect to options. So we see a very good pipeline around that and what that looks like. And that, again, that is more of a second half item. That's probably one of the larger elements of that second half growth. If we look at, you know, Australia, that new platform, that's something we see incrementally and growing over time. So that's maybe not as immediate a hit. But again, when you look at the cumulative basis and then continuing to call it incrementally increase the growth rate over prior year, right, so you The other items that we mentioned in the, you know, with the global indices, with the, you know, risk and market analytics, some of the stuff we're seeing, you know, with distribution as a service, that's more pipeline driven as we look at those clients, see what's there, looking for those signups. as far as helping to contribute, again, getting us back to that growth rate that we had laid out. Dave, I don't know if I missed any other points.
Dave Howson
President and Chief Strategy Officer
Yeah, and certainly the revenue profile for the year is really living up to our own projections and expectations. With that acceleration in the second half of this year, the uniformity of the technology with the Australia platform really does help the adoption of data, and we've seen that elsewhere, as Brian mentioned. and notably around the cloud, 17% of new users actually in Q1 came from Australia. So boots on the ground, replatforming completed, really does increase the uptake and interest in the data from the region. We've done the replatforming. And then mentioning on the indices front there, a real highlight is the options overlay indices that are really getting a lot of traction right now with our business and with our customer's. And then the risk management and analytics sleeve of the data and access solutions business, that global analytics capability that we rolled out in Q1, the addition of European data really picking up clients in Europe there as well as the pipeline looking good for the rest of the year. And as Brian said at the top, the SIBO 1 options product as part of that broader SIBO 1 family, that packaging of data, really part of the growth that we see realizing in the second half of this year.
Operator
Conference Operator
Great. Thank you. The next question comes from Owen Lau with Oppenheimer. Please go ahead.
Angela
Analyst at Oppenheimer
Good morning, and thank you for taking my question. Could you please give us a little bit more color on SIBO Digital's And I think as you talk about you're onboarding more partners, but how many more partners in your pipeline do you expect to onboard in the coming months? Do you have any timeline? And also, what is your plan to launch more new products? Thanks a lot.
Dave Howson
President and Chief Strategy Officer
Sure. Thanks for the question. So we reported in the prepared remarks there the record volumes that we've seen, in particular in February, the tightening of the spreads, the deaths improving there. The syndicate members, we're over halfway through onboarding those now and seeing the benefit as they optimize their interaction with the platform and continue to build out as we look forward. And we're looking forward to and continue to engage with CFTC on the margin futures approval.
Angela
Analyst at Oppenheimer
Okay, it's Angela.
Operator
Conference Operator
The next question comes from Brian Bedell with Deutsche Bank. Please go ahead.
Brian Bedell
Analyst at Deutsche Bank
Great. Thanks. Good morning, folks. If I can just ask one clarification question to Brian and then a strategic question around Canada. Just, Brian, I think you mentioned, if I wrote it down correctly, a $14 million gain in the other non-op line in one queue. And then reiterating the 27 to 33 guidance, I just want to see if that guidance includes that gain, which would imply like $5 million a quarter in non-op other income. And then the second question would be on the Canada strategy. It looks like you've gained about 100 basis points of market share linked quarter. And just if you can talk about, you know, your ambitions there in terms of that continued share improvement. And I believe that does not even include bids. So if you can clarify that, and then maybe just talk about the bid strategy and how, you know, your view on the momentum in Canada.
Brian Schell
Executive Vice President, CFO and Treasurer
Yeah. Short answer is yes, it does include that current gain. So as we look at that forecast and the guidance, it does include this current quarter.
Dave Howson
President and Chief Strategy Officer
And so talking to the Canadian strategy, one of the benefits in having a meaningful market share in every market open to competition is we've got a broad playbook to look to and a broad set of customers to engage and seek their counsel on where we should go next. You're right, the market share has improved, and we've been very pleased to see that. That's become from a number of tactical strands the team has deployed, the first of which is a number of execution consulting or insight pieces where we provide commentary on the relative benefits of the four books we have available for trading underneath our CBO Canada banner now. Those finding different utility with our customers as we engage them to continue trading So what you'll see in the future is continued enhancements around pricing, around functionality and feature sets. And in particular, you also mentioned bids. Bids have been a great story for us. Last quarter, I talked about having 75 buy side on the platform. Now it's 103. And in fact, only 30 of those are Canadian buy sides. There you really see the power of the global network of bids kicking in in a single quarter. If you contrast that to Europe, been well established on the number one platform. We have over 250 buy sides there. So rapidly catching up to that count in Canada. So we see great benefits of that global network for bids bringing benefit to the local Canadian marketplace there. And when you look across the world, we're 14% market share in Canada. We're 25% in April in Europe and around about 20% in Canada. So these are benchmarks that we look to as we think about where we can go.
Brian Bedell
Analyst at Deutsche Bank
Excellent. Thank you.
Operator
Conference Operator
The next question comes from Kyle Voigt with KBW. Please go ahead. Hi.
Kyle Voigt
Analyst at KBW
Good morning. Just a follow-up question for me on one-day VIX. And in terms of how SIBO potentially monetizes the development of that index, is the index really solely meant to help kind of facilitate trading, provide more market data for clients that are trading zero DTE and some other listed products, or would it also be possible to launch a derivatives product based off of one-day VIX at some point in the future? Just not sure the technical difficulties of doing that, so maybe you could expand a bit around that.
Ed Tilley
Chairman and CEO
Yeah, so the track record that we have, if you look back at VIX, VIX was first a benchmark that became a tradable futures contract. So that is – The playbook that we'll use, so right now with One Day VIX out there, the process that we've begun now is to educate. The market will digest the information, and as you can observe, this has been quite a volatile process. 50, 70, 90% moves in the one day, and the 30-day, you know, more typical, you know, 10% move. So the models and understanding measuring short-term volume and the feedback loop that we have with customers will allow our SIBO labs to explore the possibilities of a tradable product. So stay tuned. That is always the objective here is how to turn indicators that are useful to the marketplace into tradable products for various hedging and different exposures. So, yes, the plan would be to develop something that we can bring to the market that is tradable.
Kyle Voigt
Analyst at KBW
Understood. Thank you.
Operator
Conference Operator
The next question comes from Alex Blostein with Goldman Sachs. Please go ahead.
Alex Blostein
Analyst at Goldman Sachs
Hey, guys. Good morning. Thanks for taking the question. In prior meetings, you talked about increased utilization of SPX daily options by market makers to Delta Hedge, et cetera. Can you update us on any incremental details you're sort of seeing on that front, any color on what percentage of SPX volume that activity comprises today? And ultimately, how do you think about customers' view and all-in cost of doing that versus trading alternative products largely on CMEs and MEs?
Ed Tilley
Chairman and CEO
Yeah, it's a great question, and it's one that we've begun to observe, I would say, over the last six months and trending a little bit higher as the liquidity increases in the dailies. But I want to first say that the ecosystem and the power of the 500 complex for us in all of the development and all of the benchmarks in our expansion is relies on an incredibly deep, liquid futures market. So our market makers are huge, huge customers of the CME futures. We need that futures market to be deep and liquid. So we're a champion of the ecosystem in general. Now, naturally, if you're a market maker and you're trading zero-day, your ideal hedge is is an exposure that matches up with the initiating trade. So if you're opening as part of your liquidity provider obligation and selling a daily call, the least effective or the most expensive hedge you can have is a futures contract that you may have to trade out of at the end of the day. That's a two-future churn. And that's not a bad thing. But what would you rather do? you'd rather have a hedge that expires at the same time as the initial trade. That would be another option in the daily. So not surprisingly, market makers look now to a very liquid daily option market for the first hedge. And that trend, we anticipate to continue, not because the futures contract is necessarily bad. It's just that it will require, it may require at the end of the day, another futures trade where option to option both options would roll off at the same time. So that's what we talk about when we look at another use case. It is like exposure hedged like exposure. and that is not to take away from a very vibrant and liquid market across the street. So that is a trend that continues. It's just optimizing trading from a market maker's perspective. Very natural, and it's a progression because the market is so deep and so liquid in the dailies.
Operator
Conference Operator
Great. Very helpful. Thank you. The next question comes from Andrew Bond with Rosenblatt Securities. Please go ahead.
Andrew Bond
Analyst at Rosenblatt Securities
Hey, good morning. Just following up on CBOE Digital, do you guys provide any more color around your margin futures application with the CFTC and if there's been any change in discussions with the regulator given some of the recent rhetoric and enforcement actions from the SEC? And additionally, do you think approval will drive greater trading activity kind of soon after, or are you finding that customers are still waiting for greater regulatory clarity more broadly? Thanks.
Dave Howson
President and Chief Strategy Officer
Yeah, thanks, Andrew. The conversations with the CFTC continue. The application is still with the CFTC and going through the process. We have a number of SDNs lined up and ready to begin to onboard once we receive that application. And from there, once they've onboarded, things will move pretty quickly.
John Dieters
Chief Strategy Officer
Andrew, this is John. Just one other thing to note there, as we look at the environment, Things have really picked back up to where they were in 22 in terms of core nodes, in terms of active accounts on the Bitcoin network. The issue is that while a lot of that activity is in the U.S., spot trading is hampered by the regulatory environment. We think, as Dave mentioned, the derivatives products that we're preparing really change that because there's – So that's an enabler in our point of view.
Andrew Bond
Analyst at Rosenblatt Securities
Great. Thanks, guys.
Operator
Conference Operator
This concludes our question and answer session. I would like to turn the conference back over to management for any closing remarks.
Ed Tilley
Chairman and CEO
I have a closing remark, and thanks, Ken, for letting me take the opportunity. Sorry, Rich, but we want to take a moment to note that this is your last call ahead of retirement later this summer. Everyone knows Rich has just been a constant on the CBOE earnings call since our IPO in 2010, and one of the first just to understand the power of this index franchise and always highlighting the durability of our product set. So, Rich, we wish you all the best in everything you do in the future and certainly look forward to seeing you at your conference in June. So thank you so much for the years and years of coverage and dialogue.
Operator
Conference Operator
the conference has now concluded thank you for attending today's presentation you may now disconnect
Disclaimer